Tommasi; Ruben Alberto
Patent Applications and Registrations
Patent applications and USPTO patent grants for Tommasi; Ruben Alberto.The latest application filed is for "arylsulfonamide-based matrix metalloprotease inhibitors".
- Tommasi; Ruben Alberto - Stow MA
- Tommasi; Ruben Alberto - Cambridge MA US
- Tommasi; Ruben Alberto - Whitehouse Station NJ
| Patent | Date |
|---|---|
| ArylSulfonamide-based matrix metalloprotease inhibitors Grant 9,822,092 - Ehrhardt , et al. November 21, 2 | 2017-11-21 |
| Arylsulfonamide based matrix metalloprotease inhibitors Grant 8,975,439 - Tommasi , et al. March 10, 2 | 2015-03-10 |
| ArylSulfonamide-Based Matrix Metalloprotease Inhibitors App 20150045398 - EHRHARDT; Claus ; et al. | 2015-02-12 |
| Selective hydroxamic acid based MMP-12 and MMP-13 inhibitors Grant 8,841,291 - McQuire , et al. September 23, 2 | 2014-09-23 |
| Selective Hydroxamic Acid Based Mmp-12 And Mmp-13 Inhibitors App 20140031399 - MCQUIRE; Leslie Wighton ; et al. | 2014-01-30 |
| ArylSulfonamide Based Matrix Metalloprotease Inhibitors App 20130096105 - Tommasi; Ruben Alberto ; et al. | 2013-04-18 |
| Arylsulfonamide based matrix metalloprotease inhibitors Grant 8,362,063 - Tommasi , et al. January 29, 2 | 2013-01-29 |
| Selective hydroxamate based MMP inhibitors Grant 8,314,148 - Leutert , et al. November 20, 2 | 2012-11-20 |
| ArylSulfonamide Based Matrix Metalloprotease Inhibitors App 20120258954 - Ehrhardt; Claus ; et al. | 2012-10-11 |
| Selective Hydroxamate Based Mmp Inhibitors App 20120225882 - Leutert; Thomas ; et al. | 2012-09-06 |
| Selective hydroxamate based MMP inhibitors Grant 8,232,427 - Leutert , et al. July 31, 2 | 2012-07-31 |
| Arylsulfonamide-based matrix metalloprotease inhibitors Grant 8,222,424 - Ehrhardt , et al. July 17, 2 | 2012-07-17 |
| Selective Hydroxamic Acid Based Mmp-12 And Mmp-13 Inhibitors App 20110112076 - McQuire; Leslie Wighton ; et al. | 2011-05-12 |
| Arylsulfonamide-based Matrix Metalloprotease Inhibitors App 20110014186 - Ehrhardt; Claus ; et al. | 2011-01-20 |
| Selective Hydroxamate Based Mmp Inhibitors App 20090318511 - Leutert; Thomas ; et al. | 2009-12-24 |
| Dipeptide Nitriles App 20080027060 - Altmann; Eva ; et al. | 2008-01-31 |
| Azacycloalkyl substituted acetic acid derivatives for use as MMP inhibitors App 20070060569 - Fujimoto; Roger Aki ; et al. | 2007-03-15 |
| Certain azacycloalkyl substituted acetic acid derivatives App 20040235896 - Fujimoto, Roger Aki ; et al. | 2004-11-25 |
| N-substituted peptidyl nitriles as cysteine cathepsin inhibitors Grant 6,812,237 - Cowen , et al. November 2, 2 | 2004-11-02 |
| Quinazoline derivatives App 20040180912 - Beerli, Rene ; et al. | 2004-09-16 |
| Dipeptide derivatives App 20040110806 - Altmann, Eva ; et al. | 2004-06-10 |
| Dipeptide nitriles App 20040029814 - Altmann, Eva ; et al. | 2004-02-12 |
| N-substituted peptidyl nitriles as cysteine cathepsin inhibitors App 20030158256 - Cowen, Scott Douglas ; et al. | 2003-08-21 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 